Travere Therapeutics Inc (NASDAQ:TVTX)

18.22
Delayed Data
As of May 14
 -0.69 / -3.65%
Today’s Change
14.50
Today|||52-Week Range
33.09
-33.15%
Year-to-Date

Today’s Trading

Previous close18.91
Today’s open18.50
Day’s range16.69 - 18.52
Volume55,905
Average volume (3 months)609,302
Market cap$1.2B
Data as of 3:59pm ET, 05/14/2021

Growth & Valuation

Earnings growth (last year)-3.05%
Earnings growth (this year)+30.37%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+13.11%
P/E ratioNM
Price/Sales6.53
Price/Book4.95

Competitors

 Today’s
change
Today’s
% change
CDMOAvid Bioservices Inc+0.80+4.15%
ATRAAtara Biotherapeutic...+0.28+1.90%
PTGXProtagonist Therapeu...+1.47+5.07%
RYTMRhythm Pharmaceutica...+1.39+6.57%
Data as of 4:00pm ET, 05/14/2021

Financials

Next reporting dateAugust 5, 2021
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$198.3M
Annual profit (last year)-$169.4M
Net profit margin-85.43%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts